| Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation |
11 |
| [Tc-99m]Tc-duramycin, a potential molecular probe for early prediction of tumor response after chemotherapy |
11 |
| Pb-212-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models |
11 |
| What about alpha(v)beta(3) integrins in molecular imaging in oncology? |
8 |
| [F-18]F-DPA for the detection of activated microglia in a mouse model of Alzheimer's disease |
8 |
| Imaging Imaging of isoproterenol-induced myocardial injury with F-18 labeled fluoroglucaric acid in a rat model |
6 |
| Synthesis and evaluation of a novel urea-based Ga-68-complex for imaging PSMA binding in tumor |
6 |
| A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals |
6 |
| Microscale radiosynthesis, preclinical imaging and dosimetry study of [F-18]AMBF(3)-TATE: A potential PET tracer for clinical imaging of somatostatin receptors |
6 |
| Rapid and automated production of [Ga-68]gallium chloride and [Ga-68] Ga-DOTA-TATE on a medical cyclotron |
6 |
| Preliminary evaluation of a novel F-18-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer |
5 |
| An improved automated one-pot synthesis of O-(2-[F-18]fluoroethyl)-L-tyrosine ([F-18]FET) based on a purification by cartridges |
5 |
| Cyclotron production of Tc-99m Comparison of known separation technologies for isolation of Tc-99m from molybdenum targets |
5 |
| Comparison of Ga-68-labeled RGD mono- and multimers based on a clickable siderophore-based scaffold |
5 |
| Somatostatin receptor targeting with hydrophilic [Tc-99m/Re-186]Tc/Re-tricarbonyl NODAGA and NOTA complexes |
5 |
| Tc-99m labeled (D)(LPR): A novel retro-inverso peptide for VEGF receptor-1 targeted tumor imaging |
5 |
| The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates |
4 |
| Matched-pair, Y-86/Y-90-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer |
4 |
| Re(CO)(3)([F-18]FEDA), a novel F-18 PET renal tracer: Radiosynthesis and preclinical evaluation |
4 |
| Ga-68-labelled NOTA-RGD-GE11 peptide for dual integrin and EGFR-targeted tumour imaging |
4 |
| Evaluation of [C-11]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16.F10 melanoma |
4 |
| Cyclotron production of Ga-68 in a liquid target: Effects of solution composition and irradiation parameters |
4 |
| [F-18]RPS-544: A PET tracer for imaging the chemokine receptor CXCR4 |
4 |
| Robust high-yield similar to 1 TBq production of cyclotron based sodium [Tc-99m]pertechnetate |
4 |
| [Tc-99m]duramycin for cell death imaging: Impact of kit formulation, purification and species difference |
4 |
| Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours |
4 |
| Establishment of a method for in-vivo SPECT/CT imaging analysis of( 111)In-labeled exendin-4 pancreatic uptake in mice without the need for nephrectomy or a secondary probe |
4 |
| A radiopharmaceutical [Zr-89]Zr-DFO-nimotuzumab for immunoPET with epidermal growth factor receptor expression in vivo |
4 |
| Accuracy of [Ga-68]Ga-RM2-PET/CT for diagnosis of primary prostate cancer compared to histopathology |
4 |
| Preclinical study of an F-18-labeled glutamine derivative for cancer imaging |
4 |
| Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders |
4 |
| Evaluation of [F-18]pitavastatin as a positron emission tomography tracer for in vivo organic transporter polypeptide function |
3 |
| Alanine and glycine conjugates of (2S,4R)-4-[F-18]fluoroglutamine for tumor imaging |
3 |
| Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [Cu-64]-DOTHA(2)-PEG-RM26 |
3 |
| F-18-labeled norepinephrine transporter tracer [F-18]NS12137: radiosynthesis and preclinical evaluation |
3 |
| Facile radiochemical separation of clinical-grade Y-90 from Sr-90 by selective precipitation for targeted radionuclide therapy |
3 |
| Development of [F-18]FAMTO: A novel fluorine-18 labelled positron emission tomography (PET) radiotracer for imaging CYP11B1 and CYP11B2 enzymes in adrenal glands |
3 |
| Zr-89 for antibody labeling and in vivo studies - A comparison between liquid and solid target production |
3 |
| Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFR alpha) in papillary thyroid cancer using immuno-PET |
3 |
| Clinical scale synthesis of intrinsically radiolabeled and cyclic RGD peptide functionalized Au-198 nanoparticles for targeted cancer therapy |
3 |
| Gallium-68 labeled Ubiquicidin derived octapeptide as a potential infection imaging agent |
3 |
| On-cartridge preparation and evaluation of Ga-68 Zr-89- and Cu-64-precursors for cell radiolabelling |
3 |
| Ga-68[Ga]-Galmydar: Biodistribution and radiation dosimetry studies in rodents |
3 |
| Sex-differences in [Ga-68]Ga-DOTANOC biodistribution |
2 |
| Clinical evaluation of [Ga-68]Ga-DATA-TOC in comparison to [Ga-68]Ga-DOTA-TOC in patients with neuroendocrine tumours |
2 |
| F-18-labeled estradiol derivative for targeting estrogen receptor-expressing breast cancer |
2 |
| Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging |
2 |
| Ga-68-DOTATOC PET/CT in the localization of head and neck paraganglioma compared with F-18-DOPA PET/CT and I-123-MIBG SPECT/CT |
2 |
| Brush border enzyme-cleavable linkers: Evaluation for reducing renal uptake of radiolabeled prostate-specific membrane antigen inhibitors |
2 |
| Tumor uptake and tumor/blood ratios for [Zr-89]Zr-DFO-trastuzumab-DM1 on microPET/CT images in NOD/SCID mice with human breast cancer xenografts are directly correlated with HER2 expression and response to trastuzumab-DM1 |
2 |
